The clinical pharmacology of cisatracurium;Die klinische Pharmakologie von Cisatracurium

Anaesthesist

Volumn 46, Issue 6, 1997, Pages 481-485

  Mellinghoff, H ^a   Diefenbach, Ch ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

51W89; atracurium; cisatracurium

Indexed keywords

ATRACURIUM; ATRACURIUM BESILATE; CISATRACURIUM;

ADULT; AGE; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG METABOLISM; DRUG POTENCY; HUMAN; INTENSIVE CARE; KIDNEY FAILURE; NEUROMUSCULAR BLOCKING; NORMAL HUMAN;

ADULT; ANESTHESIA; ATRACURIUM; HUMANS; NEUROMUSCULAR BLOCKING AGENTS;

EID: 0030791675     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010050427     Document Type: Article

References (30)

1. Belmont MR, Lien CA, Quessy S, Abou-Donia MM, Abalos A, Eppich L, Savarese JJ (1995) The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/ barbiturate anesthesia. Anesthesiology 82:1139-1145
2. Boyd AH, Eastwood NB, Parker CJR, Hunter JM (1995) Pharmacodynamics of the 1R cis-1′R cis isomer of atracurium (51W89) in health and chronic renal failure. Br J Anaesth 74:400-404
3. Chapple DJ, Miller AA, Ward JB, Wheatley PL (1987) Cardiovascular and neurological effects of laudanosine. Studies in mice and rats, and in conscious and anaesthetized dogs. Br J Anaesth 59:218-225
4. Deriaz H, Schmautz E, Vrillon M, Lienhart A (1994) Pharmacodynamics of repeated doses of 51W89 during surgery. Anesthesiology 81:A1092
5. Eastwood NB, Boyd AH, Parker CJR, Hunter JM (1995) Pharmacokinetics of 1R-cis 1′R-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure. Br J Anaesth 75:431-435
6. Eddelston JM, Harper NJN, Pollard BJ, Edwards D, Gwinnutt CL (1989) Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma during intracranial surgery. Br J Anaesth 63:525-530
7. Kisor DF, Wargin WA, Schmith VD, Cook DR, Ornstein E (1994) Organ-independent Hofmann elimination is the major clearance pathway of the neuromuscular blocking agent cisatracurium. Pharm Res 11:S335
8. ®) in patients with coronary artery disease. Anesth Analg 81:1010-1014
9. Lepage JY, Malinovsky JM, Malinge M, Cozian A, Pinaud M (1993) 51W89: dose-response, neuromuscular blocking profile and cardiovascular effects. Anesthesiology 79:A945
10. Lepage JY, Malinovsky JM, Malinge M, Cozian A, Pinaud M (1994) Pharmacodynamics and histamine releasing potency of high dose of 51W89. Anesthesiology 81:A1077
11. Lien CA, Belmont MR, Abalos A, ABou-Donia M, Savarese JJ (1993) Dose-response relations of 51W89 under nitrous-oxide-opioid-barbiturate anesthesia. Anesthesiology 79:A948
12. Lien CA, Belmont MR, Abalos A, Eppich L, Quessy S, Abou-Donia MM, Savarese JJ (1995) The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 82:1131-1138
13. Lien CA, Schmith VD, Belmont MR, Abalos A, Kisor DF, Savarese JJ (1996) Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 84:300-308
14. Littlejohn IH, Abhay K, El Sayed A, Broomhead CJ, Duvaldestin P, Flynn PJ (1995) Intubating conditions following 1R CIS, 1′R CIS atracurium (51W89) - A comparison with atracurium. Anaesthesia 50:499-502
15. Mellinghoff H, Diefenbach C, Buzello W (1995) Administration of 51W89 by infusion - a comparison with atracurium - preliminary communication. Acta Anaesthesiol Scand 39:95
16. Meretoja OA, Taivainen T, Wirtavuori K (1995) Pharmacodynamic effects of 51W89, an isomer of atracurium, in children during halothane anaesthesia. Br J Anaesth 74:6-11
17. Miller RD, Rupp SM, Fisher DM, Cronnelly R, Fahey MR, Sohn YJ (1984) Clinical pharmacology of vecuronium and atracurium. Anesthesiology 61:444-453
18. Ornstein E, Lien C, Matteo RS, Ostapkovich N, Diaz J, Wolf KB (1996) Pharmacodynamics and pharmacokinetics in Cisatracurium in geriatric surgical patients. Anesthesiology 84:520-525
19. Oyos TL, Lillehaug SL, Harley PJ, Patel SS, Gergis SD, Sokoll MD (1994) A study of the safety and efficacy of 51W89 in surgical patients during N20/02/opioid, N20/02/isoflurane, N20/02/enflurane, and N20/02/propofol anesthesia. Anesthesiology 81:A1117
20. Pavlin EG, Duvaldestin P, Belmont MR, Flynn RJ (1996) The use of Cisatracurium for tracheal intubation. Curr Opin Anaesthesiol 9:S23-S26
21. Prielipp RC, Coursin DB, Scuderi PE, Bowton DL, Ford SR, Cardenas VJ, Vender J, Howard D, Casale EJ, Murray MJ (1995) Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg 81:3-12
22. Reilly CS, Nimmo WS (1987) New intravenous anaesthetics and neuromuscular blocking drugs. Drugs 34:98-135
23. Savarese JJ, Ali HH, Basta SJ, Scott RPF, Embree PB, Wastila WB, ABou-Dinia MM, Gelb C (1989) The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesia. Anesthesiology 70:386-394
24. Savarese JJ, Deriaz H, Mellinghoff H, Pavlin EG, Sokoll MD (1996) The pharmacodynamics of cisatracurium in healthy adults. Curr Opin Anaesthesiol 9:S16-S22
25. Scott RPF, Savarese JJ, Basta SJ, Sunder N, Ali HH, Gargarian M, Gionfriddo M, Batson AG (1985) Atracurium: clinical strategies for preventing histamine release and attenuating the haemodynamic response. Br J Anaesth 57:550-553
26. Stout RG, Belmont MR, Pavlin EG, Abalos A, Lien CA (1994) Evaluation of intubation at 90 and 120 seconds following 51W89 administration. Anesthesiology 81:A1078
27. Tullock W, Scott V, Smith DA, Phillips L, Cook DR (1994) Kinetics/Dynamics of 51W89 in liver transplant patients and healthy patients. Anesthesiology 81:A1076
28. Wastila WB, Maehr RB, LaMunion GL, Belmont MR, Savarese JJ (1996) Preclinical pharmacology of cisatracurium besylate. Curr Opin Anaesthesiol 9:S2-S8
29. Welch RM, Brown A, Ravitch J, Dahl R (1995) The in vitro degradation of cisatracurium, the R, cis-R′-Isomer of atracurium, in human and rat plasma. Clin Pharmacol Ther 58:132-142
30. Vlasselaers D, Mulier JP, Berg H, Hom A, van Aken H (1994) Haemodynamic effects of a potent isomer of atracurium (51W89) in cardiac patients. Anesthesiology 81:A1079